William Mulholland joins DLA Piper’s Patent Prosecution practice in Phoenix

DLA Piper announced today that William Mulholland has joined the firm’s Patent Prosecution practice and Life Sciences sector as a partner in Phoenix.

Mulholland focuses on patent prosecution and counseling related to licensing, litigation and procurement. His life sciences practice includes small molecule chemistry and biologic therapeutics, as well as diagnostics, drug discovery and drug delivery. His agribusiness practice similarly focuses on chemical and biologic-based active ingredients, as well as formulation and chemical process technologies.

“Bill’s arrival significantly enhances our growing life sciences and patent prosecution capabilities,” said Larissa Bifano, US chair of DLA Piper’s Patent Prosecution practice. “He brings valuable in-house experience in the pharmaceutical and agribusiness fields, as well as a strong scientific background and a history of representing emerging life sciences companies that will be highly beneficial to our clients.”

“As we continue to build our life sciences practice across our global platform, Bill’s diverse skillset and deep experience in the sector will enhance our transactional practice and improve the strength of our strategic prosecution team, allowing us to better meet the high demand for sophisticated intellectual property representation,” said Andrew Gilbert, global co-chair of the firm’s Life Sciences sector.

Mulholland joins from Snell & Wilmer LLP, where he served as co-chair of the Life Sciences and Medical Technology group. He received his J.D. from the University of Southern California, Gould School of Law, his M.A. in molecular biology from Brown University and his B.S. in biochemistry from the University of Arizona.